ALST Allstar Health Brands Inc (PK)

TORONTO, ON--(Marketwired - Jun 16, 2014) - Axxess Pharma Inc. (PINKSHEETS: AXXE) a specialty pharmaceutical and nutritional supplements company is pleased to announce through its wholly-owned subsidiary, AllStar Health Brands Inc., that they have received their first purchase order from Australian distributor Hardcore Beverages. The purchase order is for AllStar Health Brands', TapouT Muscle Recovery Pain Relief, Muscle Growth Supplement and TapouT Muscle Post Recovery Supplement.

The purchase order marks AllStar's continued expansion of products into new countries, fueled by its high demand TapouT line. Hardcore Beverages and AllStar anticipate strong residual sales within the Australian beverage market.

As a direct result of Hardcore Beverages' marketing strategies, they are a major supporter of Australian sports and its athletes. From MMA, to motorsports, including V8 Utes and FMX, Hardcore Beverages is committed to giving their homegrown Aussie athletes the support they need to achieve their dreams. The TapouT product line was quickly determined to be the perfect synergy for the rapidly growing Australian distributor.

Hardcore Beverages and AllStar are now also in development of a new product line to be released to the public within the next 30 days. For more information on Hardcore Beverages, please visit: http://www.hardcorebeverages.com.au/

"We are very excited to enter the Australian market and receive our first purchase order from Hardcore Beverages. They have a large customer base, and expansion plans into other Asian markets and we anticipate this will be the first of many purchase orders," said Dr. Daniel Bagi, President of All Star Brands.

"Hardcore Beverages see our partnership with All Star Health Brands as an incredible opportunity on a global scale. Our mutual commitment to all natural supplement products allows us to source the highest quality Australian ingredients renowned worldwide for purity and effectiveness. Supporting local Australian industry is important to us and we envisage the benefits of this partnership to be spread across a wide sector of the Australian economy. Protein products represent a massive retail growth sector and we look forward to working with All Star Health Brands to continue to develop healthy, technologically advanced formulas to benefit everyone," said Steve Ross, CEO of Hardcore Beverage Pty Ltd.

About Axxess Pharma Inc.: Axxess Pharma Inc. is a Nevada Corporation operating through its wholly owned Canadian Subsidiary: Axxess Pharma Canada Inc., headquartered in Toronto. Axxess is a specialty Health Care Products Company dedicated to improving health and quality of life by offering select medicines, nutritional supplements and over the counter remedies all across the Americas. Axxess's goal is to bring additional products to the market and provide new, innovative options for better health spanning areas such as high cholesterol, blood pressure, acute pain -- to optimal health management through improved nutritional supplements. To learn more about our new products TapouT Extreme Muscle Growth and TapouT Muscle Recovery, please visit: http://buytapoutme.com and http://www.tapoutmusclerecovery.com.

For more information, please visit www.axxesspharmainc.com, or contact Investor Relations at (973) 351-3868.

About TapouT: TapouT is a lifestyle brand that has been at the forefront of Mixed Martial Arts since its inception in 1997. The label is rapidly growing into other sports and categories, offering merchandise for men, women and kids. TapouT has endorsed high-profile professional athletes who compete in sports such as basketball, football, baseball, stock car racing, and most famously, MMA. TapouT is sold in sporting goods stores, specialty retailers and online. For updates and more information, please visit TapouT.com.

https://www.facebook.com/TapouT

https://twitter.com/TapouT

http://www.youtube.com/tapout

Safe Harbor Statement

Statements about the Company's future expectations and all other statements in this press release other than historical facts, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby.

The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management, as well as assumptions made by any information currently available to the Company or its management. When used in this document, the words "anticipate," "estimate," "expect," "intend," "plans," "projects," and similar expressions, as they relate to the Company or its management, are intended to identify forward-looking statements. Such statements reflect the current view of the Company regarding future events and are subject to certain risks, uncertainties and assumptions, including the risks and uncertainties noted. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove to be incorrect, actual results may vary materially from those described herein as anticipated, believed considered in light of the accompanying meaningful cautionary statements herein. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, the impact of competitive services and pricing and general economic risks, estimated, expected, intended or projected. In each instance, forward-looking information should be and uncertainties.

Contact: Investor Relations Taylor Capitol, Inc. Stephen Taylor (973) 351-3868 staylor@TheStockAlerts.com www.TheStockAlerts.com Media Relations: Jamie Schnee - PR Nutritional Products International (561) 544-0719 jamies@inhealthmedia.com

Allstar Health Brands (PK) (USOTC:ALST)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025

Allstar Health Brands (PK) (USOTC:ALST)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025